Libo Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Libo Sun has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Aiying Zhang
Beijing Institute of Hepatology Beijing You'an Hospital Capital Medical University Beijing China
1 shared publication- Bo Sun
Department of Pediatrics, National Health Commission Laboratory of Neonatal Diseases, National Children’s Medical Center and Children’s Hospital of Fudan University, China
1 shared publication Boxun Jin
Department of Hepatobiliary Surgery Beijing You'an Hospital Capital Medical University Beijing China
1 shared publication- Dong
Departments of Pediatrics and Obstetrics, Chuzhou District Hospital, Huai’an, Jiangsu, 223200, China
1 shared publication Dongdong Lin
Department of Hepatobiliary Surgery Beijing You'an Hospital Capital Medical University Beijing China
1 shared publication- Fan
Departments of Pediatrics and Obstetrics, Huaiyin District Hospital, Huai’an, Jiangsu, 223300, China
1 shared publication
Latest Publications
- Open Access
- 27 September 2018
- Published by Wiley in Cancer Medicine
- Vol. 7 (10) , 5178-5186
Distinctive pattern of AHNAK methylation level in peripheral blood mononuclear cells and the association with HBV ‐related liver diseases
The purpose of this study was to investigate the correlation between AHNAK methylation level in peripheral blood mononuclear cells ( PBMC ) and the progression of hepatitis B virus ( HBV )‐related liver disease. Bioinformatics methods were applied to evaluate the AHNAK methylation level in PBMC and T cells at different stages of HBV related liver disease, to investigate the correlation between AHNAK methylation and clinical features, as well as to compare the methylation site of AHNAK in cancer tissues and adjacent tissues. Subsequently, the differentially expressed gene analysis technique was used to analyze the liver disease‐related genes and immune‐related pathways in hepatitis B patients with different pathological changes. Finally, promoter methylation and mRNA expression of AHNAK gene in liver cancer and adjacent tissues were determined by quantitative polymerase chain reaction (Q‐ PCR ), and the diagnostic value of AHNAK methylation level in hepatopathy was evaluated by receiver operating characteristic ( ROC ) curve. The promoter methylation level of AHNAK gene in PBMC s decreased with the progression of HBV ‐related liver disease, and showed significant difference among the patients with various HBV ‐related liver diseases ( P = 0.0001). The AHNAK methylation level in PBMC s and T cells was negatively associated with age, white blood cell count, CREA , drinking, and positively associated with APTT and HbsAg. Higher mRNA expression of AHNAK was found in liver cancer tissues than that of adjacent tissues ( P < 0.001), and the methylation level in PBMC decreased with the progression of hepatitis B‐related liver disease. The area under the ROC curve ( ROC ) was 0.883 ( P < 0.001) in diagnosis of chronic hepatitis B ( CHB ), 0.885 ( P < 0.001) in diagnosis of compensatory liver cirrhosis, 0.955 ( P < 0.001) in diagnosis of decompensated liver cirrhosis, 0.981 ( P < 0.001) in diagnosis of hepatocellular carcinoma. Our results revealed that AHNAK methylation level in peripheral blood decreases with the progression of hepatitis B‐related liver disease. This provided a potential differential diagnostic method for HBV ‐related hepatopathies, and thus an early detective tool for liver cancer.
- 27 September 2018
- Published by Wiley in Cancer Medicine
- Vol. 7 (10) , 5178-5186
Open AccessDistinctive pattern of AHNAK methylation level in peripheral blood mononuclear cells and the association with HBV ‐related liver diseases
The purpose of this study was to investigate the correlation between AHNAK methylation level in peripheral blood mononuclear cells ( PBMC ) and the progression of hepatitis B virus ( HBV )‐related liver disease. Bioinformatics methods were applied to evaluate the AHNAK methylation level in PBMC and T cells at different stages of HBV related liver disease, to investigate the correlation between AHNAK methylation and clinical features, as well as to compare the methylation site of AHNAK in cancer tissues and adjacent tissues. Subsequently, the differentially expressed gene analysis technique was used to analyze the liver disease‐related genes and immune‐related pathways in hepatitis B patients with different pathological changes. Finally, promoter methylation and mRNA expression of AHNAK gene in liver cancer and adjacent tissues were determined by quantitative polymerase chain reaction (Q‐ PCR ), and the diagnostic value of AHNAK methylation level in hepatopathy was evaluated by receiver operating characteristic ( ROC ) curve. The promoter methylation level of AHNAK gene in PBMC s decreased with the progression of HBV ‐related liver disease, and showed significant difference among the patients with various HBV ‐related liver diseases ( P = 0.0001). The AHNAK methylation level in PBMC s and T cells was negatively associated with age, white blood cell count, CREA , drinking, and positively associated with APTT and HbsAg. Higher mRNA expression of AHNAK was found in liver cancer tissues than that of adjacent tissues ( P < 0.001), and the methylation level in PBMC decreased with the progression of hepatitis B‐related liver disease. The area under the ROC curve ( ROC ) was 0.883 ( P < 0.001) in diagnosis of chronic hepatitis B ( CHB ), 0.885 ( P < 0.001) in diagnosis of compensatory liver cirrhosis, 0.955 ( P < 0.001) in diagnosis of decompensated liver cirrhosis, 0.981 ( P < 0.001) in diagnosis of hepatocellular carcinoma. Our results revealed that AHNAK methylation level in peripheral blood decreases with the progression of hepatitis B‐related liver disease. This provided a potential differential diagnostic method for HBV ‐related hepatopathies, and thus an early detective tool for liver cancer.
- Open Access
- 30 September 2014
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 14 (1) , 338
Estimation of high risk pregnancy contributing to perinatal morbidity and mortality from a birth population-based regional survey in 2010 in China
Neonatal mortality reduction in China over past two decades was reported from nationwide sampling surveys, however, how high risk pregnancy affected neonatal outcome is unknown. The objective of this study was to explore relations of pregnancy complications and neonatal outcomes from a regional birth population. In a prospective, cross-sectional survey of complete birth population-based data file from 151 level I-III hospitals in Huai’an region in 2010, pregnancy complications were analyzed for perinatal morbidity and mortality in association with maternal and perinatal characteristics, hospital levels, mode of delivery, newborn birth weight and gestational age, using international definition for birth registry and morbidities. Pregnancy complications were found in 10% of all births, in which more than 70% were delivered at level II and III hospitals associated with higher proportions of fetal and neonatal death, preterm birth, death at delivery and congenital anomalies. High Cesarean section delivery was associated with higher pregnancy complications, and more neonatal critical illnesses. The pregnancy complications related perinatal morbidity and mortality in level III were 2–4 times as high as in level I and II hospitals. By uni- and multi-variate regression analysis, impact of pregnancy complications was along with congenital anomalies and preterm birth, and maternal child-bearing age and school education years contributing to the prevalence. This survey revealed variable links of pregnancy complications to perinatal outcome in association with very high Cesarean section deliveries, which warrants investigation for causal relations between high risk pregnancy and neonatal outcome in this emerging region.
- 30 September 2014
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 14 (1) , 338
Open AccessEstimation of high risk pregnancy contributing to perinatal morbidity and mortality from a birth population-based regional survey in 2010 in China
Neonatal mortality reduction in China over past two decades was reported from nationwide sampling surveys, however, how high risk pregnancy affected neonatal outcome is unknown. The objective of this study was to explore relations of pregnancy complications and neonatal outcomes from a regional birth population. In a prospective, cross-sectional survey of complete birth population-based data file from 151 level I-III hospitals in Huai’an region in 2010, pregnancy complications were analyzed for perinatal morbidity and mortality in association with maternal and perinatal characteristics, hospital levels, mode of delivery, newborn birth weight and gestational age, using international definition for birth registry and morbidities. Pregnancy complications were found in 10% of all births, in which more than 70% were delivered at level II and III hospitals associated with higher proportions of fetal and neonatal death, preterm birth, death at delivery and congenital anomalies. High Cesarean section delivery was associated with higher pregnancy complications, and more neonatal critical illnesses. The pregnancy complications related perinatal morbidity and mortality in level III were 2–4 times as high as in level I and II hospitals. By uni- and multi-variate regression analysis, impact of pregnancy complications was along with congenital anomalies and preterm birth, and maternal child-bearing age and school education years contributing to the prevalence. This survey revealed variable links of pregnancy complications to perinatal outcome in association with very high Cesarean section deliveries, which warrants investigation for causal relations between high risk pregnancy and neonatal outcome in this emerging region.